Navigation Links
JCI table of contents: Oct. 19, 2009
Date:10/19/2009

EDITOR'S PICK: The protein APC slows Lou Gehrig's disease in mice

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that causes progressive weakness, disability, and death. Treatments are largely palliative. Using mice carrying the mutated form of the human SOD1 gene that causes inherited forms of ALS, however, Berislav Zlokovic and colleagues, at the University of Rochester Medical Center, Rochester, have now found that administration of the protein APC slows disease progression and extends survival. The authors therefore suggest that strategies designed to activate APC might be of benefit to patients with inherited, and possibly sporadic, ALS. However, in an accompanying commentary, Charles Esmon and Jonathan Glass warn that such an approach would not be without risks.

In the study, administration of both APC, whose main function is to prevent blood clotting, and APC analogs with a reduced ability to prevent blood clotting slowed disease progression in the mutant SOD1expressing mice and extended their survival, even when the compounds were administered after disease onset. Further analysis indicated that these compounds were able to access the brain and that once there, they worked by decreasing expression of the mutant SOD1 in several cell types in the brain, including the nerve cells destroyed in individuals with ALS. This study therefore indicates that APC can have a neuroprotective effect in mouse models of inherited ALS.

TITLE: Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells

AUTHOR CONTACT:
Berislav V. Zlokovic
University of Rochester Medical Center, Rochester, New York, USA.
Phone: (585) 273-3132; Fax: (585) 273-3133; E-mail: berislav_zlokovic@urmc.rochester.edu.

View this article at: http://www.jci.org/articles/view/38476?key=6a5479a67edd727312aa

ACCOMPANYING COMMENTARY
TITLE: The APCs of neuroprotection

AUTHOR CONTACT:
Charles T. Esmon
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Phone: (405) 271-6474; Fax: (405) 271-2872; E-mail: Charles-Esmon@omrf.org.

View the PDF of this article at: https://www.the-jci.org/article.php?id=40682


VASCULAR BIOLOGY: Too much of the protein building block homocysteine inhibits blood vessel formation

TITLE: Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2dependent fibrinolysis

AUTHOR CONTACT:
Katherine A. Hajjar
Weill Cornell Medical College, New York, New York, USA.
Phone: (212) 746-2034; Fax: (212) 746-8809; E-mail: khajjar@med.cornell.edu.

View this article at: http://www.jci.org/articles/view/39591?key=5eb08d461852e7429305

ACCOMPANYING COMMENTARY
TITLE: Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology

AUTHOR CONTACT:
Joseph Loscalzo
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Phone: (617) 732-6340; Fax: (617) 732-6439; E-mail: jloscalzo@partners.org.

View the PDF of this article at: https://www.the-jci.org/article.php?id=40924


ONCOLOGY: Loss of the protein Smad4 associated with head and neck cancer

TITLE: Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation

AUTHOR CONTACT:
Shi-Long Lu
University of Colorado Denver, Aurora, Colorado, USA.
Phone: (303) 724-0784; Fax: (303) 724-4553; E-mail: shi-long.lu@ucdenver.edu.

Xiao-Jing Wang
University of Colorado Denver, Aurora, Colorado, USA.
Phone: (303) 724-3001; Fax: (303) 724-4730; E-mail: xj.wang@ucdenver.edu.

View this article at: http://www.jci.org/articles/view/38854?key=fc4a2214d5fa7fb45183

ACCOMPANYING COMMENTARY
TITLE: Smad4: gatekeeper gene in head and neck squamous cell carcinoma

AUTHOR CONTACT:
Murray Korc
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Phone: (603) 650-7936; Fax: (603) 650-6122; E-mail: murray.korc@dartmouth.edu.

View the PDF of this article at: https://www.the-jci.org/article.php?id=41230


NEPHROLOGY: ARH: another link in the molecular chain regulating potassium levels

TITLE: The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney

AUTHOR CONTACT:
Paul A. Welling
University of Maryland School of Medicine, Baltimore, Maryland, USA.
Phone: (410) 706-3851; Fax: (410) 706-8341; E-mail: pwelling@umaryland.edu.

View this article at: http://www.jci.org/articles/view/37950?key=eba726374c485034e543


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Related medicine news :

1. Detecting the undetectable in prostate cancer screening
2. Drugs for Irritable Bowel Might Increase Cancer Risk
3. Not Getting Enough Fruits and Vegetables? Think Frozen! Antioxidant-rich Frozen Wild Blueberries are Convenient and Just As Nutritious As Fresh
4. Fabled vegetable lamb plant contains potential treatment for osteoporosis
5. Over 800 Lives of Domestic Violence Survivors Restored by the American Academy of Cosmetic Dentistry Charitable Foundations Give Back A Smile Program
6. Discrete Reportable Transcription to Populate the EHR/EMR With Physician Dictated Reports
7. Certain Types of Infertility Are Preventable
8. Long-Term Back Pain Not Inevitable, Study Finds
9. New Book Provides Alcoholics with Hope for Stable, Long-Term, Craving-Free Sobriety
10. OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover
11. A New Jersey Anti-Poverty Charity Meets a Crisis of Need with Charitable Giving from Local Paterson, NJ Small Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: